Nestlé Health Science hosted a satellite symposium at the EAACI FAAM Digital Congress in December 2022. Three speakers covered new research into the effects of Human Milk Oligosaccharides(HMO) and how they play a role in cow’s milk allergy.
|
Mechanisms of HMO in Modulating Immune Responses
Professor Liam O´MahonyProfessor of Immunology, Departments of Medicine and Microbiology, National University of Ireland
|
|
|
An extensively hydrolyzed formula supplemented with two HMOs shapes the fecal microbiome and metabolome in infants with cow´s milk proeting allergy Dr. Claire BoulangéMetabolites Specialist, Nestlé Institute of Health Sciences, Nestlé Research, Lausanne SwitzerlandDr Claire Boulangé presents the latest published study results on the effects of 2’FL and LNnT on the microbiome and metabolome in infants with CMPA. Amongst other things she covers the results showing how HMO affects the amino acid catabolism pathway, SFCA production and bile acid deconjugation.
|
|
|
Clinical relevance of 2´FL and LNnT in the nutritional management of CMPA |
Can Human Milk Oligosaccharides modulate the allergic response and improve the management of cow's milk protein allergy?


